Sisram Medical Ltd
Sisram Medical Ltd 1696.HK Peers
See (1696.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 1696.HK | HK$4.66 | +3.79% | 2.2B | 11.10 | HK$0.42 | +3.39% |
| 2252.HK | HK$15.60 | +3.45% | 16B | -21.67 | -HK$0.72 | N/A |
| 0853.HK | HK$7.70 | +5.77% | 14.2B | -8.11 | -HK$0.95 | N/A |
| 2172.HK | HK$12.26 | +19.96% | 7.2B | 25.54 | HK$0.48 | +1.55% |
| 1302.HK | HK$1.56 | N/A | 6.9B | 26.00 | HK$0.06 | N/A |
| 1789.HK | HK$5.86 | +3.17% | 6.5B | 22.54 | HK$0.26 | +0.77% |
| 6606.HK | HK$14.14 | N/A | 6.3B | 58.92 | HK$0.24 | N/A |
| 1858.HK | HK$10.90 | +2.25% | 6.3B | 30.28 | HK$0.36 | +4.48% |
| 2190.HK | HK$19.06 | +1.06% | 5.9B | 57.76 | HK$0.33 | N/A |
| 1763.HK | HK$13.12 | +0.77% | 4.2B | 9.51 | HK$1.38 | +5.62% |
Stock Comparison
1696.HK vs 2252.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2252.HK has a market cap of 16B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2252.HK trades at HK$15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2252.HK's P/E ratio is -21.67. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2252.HK's ROE of -2.32%. Regarding short-term risk, 1696.HK is more volatile compared to 2252.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 0853.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 0853.HK has a market cap of 14.2B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 0853.HK trades at HK$7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 0853.HK's P/E ratio is -8.11. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 0853.HK's ROE of -0.33%. Regarding short-term risk, 1696.HK is less volatile compared to 0853.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2172.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2172.HK has a market cap of 7.2B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2172.HK trades at HK$12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2172.HK's P/E ratio is 25.54. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2172.HK's ROE of +0.15%. Regarding short-term risk, 1696.HK is less volatile compared to 2172.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 1302.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 1302.HK has a market cap of 6.9B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 1302.HK trades at HK$1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 1302.HK's P/E ratio is 26.00. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 1302.HK's ROE of +0.06%. Regarding short-term risk, 1696.HK is more volatile compared to 1302.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 1789.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 1789.HK has a market cap of 6.5B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 1789.HK trades at HK$5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 1789.HK's P/E ratio is 22.54. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 1789.HK's ROE of +0.11%. Regarding short-term risk, 1696.HK is more volatile compared to 1789.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 6606.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 6606.HK has a market cap of 6.3B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 6606.HK trades at HK$14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 6606.HK's P/E ratio is 58.92. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 6606.HK's ROE of -0.04%. Regarding short-term risk, 1696.HK is less volatile compared to 6606.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 1858.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 1858.HK has a market cap of 6.3B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 1858.HK trades at HK$10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 1858.HK's P/E ratio is 30.28. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 1858.HK's ROE of +0.04%. Regarding short-term risk, 1696.HK is more volatile compared to 1858.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2190.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2190.HK has a market cap of 5.9B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2190.HK trades at HK$19.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2190.HK's P/E ratio is 57.76. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2190.HK's ROE of +0.03%. Regarding short-term risk, 1696.HK is more volatile compared to 2190.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 1763.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 1763.HK has a market cap of 4.2B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 1763.HK trades at HK$13.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 1763.HK's P/E ratio is 9.51. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 1763.HK's ROE of +0.08%. Regarding short-term risk, 1696.HK is more volatile compared to 1763.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 9996.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 9996.HK has a market cap of 3.6B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 9996.HK trades at HK$5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 9996.HK's P/E ratio is -14.81. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 9996.HK's ROE of -0.11%. Regarding short-term risk, 1696.HK is more volatile compared to 9996.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2500.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2500.HK has a market cap of 2.5B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2500.HK trades at HK$5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2500.HK's P/E ratio is -3.18. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2500.HK's ROE of -0.23%. Regarding short-term risk, 1696.HK is less volatile compared to 2500.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2235.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2235.HK has a market cap of 2.4B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2235.HK trades at HK$5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2235.HK's P/E ratio is -36.37. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2235.HK's ROE of -0.03%. Regarding short-term risk, 1696.HK is more volatile compared to 2235.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 6669.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 6669.HK has a market cap of 2.3B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 6669.HK trades at HK$7.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 6669.HK's P/E ratio is 41.83. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 6669.HK's ROE of +0.04%. Regarding short-term risk, 1696.HK is more volatile compared to 6669.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2160.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2160.HK has a market cap of 2.1B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2160.HK trades at HK$0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2160.HK's P/E ratio is -43.50. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2160.HK's ROE of -0.02%. Regarding short-term risk, 1696.HK is more volatile compared to 2160.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 6609.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 6609.HK has a market cap of 1.1B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 6609.HK trades at HK$28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 6609.HK's P/E ratio is -71.79. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 6609.HK's ROE of -0.01%. Regarding short-term risk, 1696.HK is more volatile compared to 6609.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2216.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2216.HK has a market cap of 1B. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2216.HK trades at HK$1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2216.HK's P/E ratio is -8.21. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2216.HK's ROE of -0.09%. Regarding short-term risk, 1696.HK is less volatile compared to 2216.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2170.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2170.HK has a market cap of 768M. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2170.HK trades at HK$2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2170.HK's P/E ratio is -2.76. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2170.HK's ROE of -0.20%. Regarding short-term risk, 1696.HK is more volatile compared to 2170.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 6118.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 6118.HK has a market cap of 369.1M. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 6118.HK trades at HK$0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 6118.HK's P/E ratio is 24.00. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 6118.HK's ROE of +0.02%. Regarding short-term risk, 1696.HK is more volatile compared to 6118.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 1612.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 1612.HK has a market cap of 254.1M. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 1612.HK trades at HK$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 1612.HK's P/E ratio is 3.59. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 1612.HK's ROE of +0.12%. Regarding short-term risk, 1696.HK is more volatile compared to 1612.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2297.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2297.HK has a market cap of 239.4M. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2297.HK trades at HK$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2297.HK's P/E ratio is -1.86. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2297.HK's ROE of -0.26%. Regarding short-term risk, 1696.HK is less volatile compared to 2297.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1696.HK.
1696.HK vs 2393.HK Comparison
1696.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1696.HK stands at 2.2B. In comparison, 2393.HK has a market cap of 214.5M. Regarding current trading prices, 1696.HK is priced at HK$4.66, while 2393.HK trades at HK$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1696.HK currently has a P/E ratio of 11.10, whereas 2393.HK's P/E ratio is 0.21. In terms of profitability, 1696.HK's ROE is +0.05%, compared to 2393.HK's ROE of +1.71%. Regarding short-term risk, 1696.HK is less volatile compared to 2393.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1696.HK.